Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2003
05/28/2003CN1109499C Fungicide active substance combinations
05/27/2003US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
05/27/2003US6569890 Cyclic AMP-specific phosphodiesterase inhibitors
05/27/2003US6569888 Such as ethyl-N-(dichlorobenzyl)-4-(3-hydroxypropylthio) indole-2-carboxylate; for treatment of arthritis
05/27/2003US6569885 Cyclic AMP-specific phosphodiesterase inhibitors
05/27/2003US6569871 Substituted imidazole compounds
05/27/2003US6569856 Treatment of feeding disorders, obesity, bulimia nervosa, sexual/reproductive disorders, depression, epileptic seizure, cardiovascular disorders, sleep disturbances
05/27/2003US6569855 Particularly zinc metalloprotease activity for treatment of variety of maladies involving inflammation and/or tissue integrity
05/27/2003US6569851 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
05/27/2003US6569849 N-Substituted azaheterocyclic compounds
05/27/2003US6569847 Inhibitors of cathepsins for treating muscular dystrophy, osteoporosis, rheumatoid arthritis, neuronal or cardiac ischaemia, allergy, or Chagas disease
05/27/2003US6569470 Monoamine oxidase (MAO) inhibitors and uses thereof
05/27/2003US6569453 No enteric layers and are suitable for oral administration
05/27/2003US6569402 Vitronectin receptor antagonist pharmaceuticals
05/27/2003CA2268847C Substituted oximes derivatives useful as neurokinin antagonists
05/27/2003CA2213054C Novel bis(imido) derivatives, a process for their preparation and pharmaceutical compositions containing them
05/27/2003CA2066104C Benzazepine derivatives as vasopressin antagonists
05/22/2003WO2003042208A1 Pyrazole derivatives as psychopharmaceuticals
05/22/2003WO2003042206A1 Pyridinone and pyrimidinone compounds
05/22/2003WO2003042205A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003WO2003042204A1 Amine derivative
05/22/2003WO2003042197A1 Oligopeptides and compositions containing them as cathepsin s inhibitors
05/22/2003WO2003042188A1 Triazole derivative and medicinal composition containing the same
05/22/2003WO2003042187A1 Serin protease inhibitors
05/22/2003WO2003042185A1 Xanthine oxidase inhibitors
05/22/2003WO2003042183A1 Process for production of pyrazole compounds
05/22/2003WO2003042181A1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivatives or salts thereof
05/22/2003WO2003042179A1 Heterocyclic derivatives of glycinamide and their medical use
05/22/2003WO2003042178A1 Novel piperidine derivatives as modulators of chemokine receptors
05/22/2003WO2003042177A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003WO2003042176A1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation
05/22/2003WO2003042175A1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
05/22/2003WO2003042174A1 Cannabinoid receptor ligands
05/22/2003WO2003042173A1 Nk1 antagonists
05/22/2003WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042160A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042147A1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents
05/22/2003WO2003041715A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
05/22/2003WO2003041714A1 Benzotriazepines as gastrin and cholecystokinin receptor ligands
05/22/2003WO2003041712A1 Pyridone, pyridazone and triazone derivatives as lp-pla2 inhibitors
05/22/2003WO2003041708A1 Benzimidazoles useful as protein kinase inhibitors
05/22/2003WO2003041644A2 Method to treat cystic fibrosis
05/22/2003WO2003022280A3 3-glyoxlylamideindoles for treating cancer
05/22/2003WO2003020699A3 Tyrosine kinase inhibitors
05/22/2003WO2003018004A3 Analgetic pyrroline derivatives
05/22/2003WO2003007883A3 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
05/22/2003WO2002085886A3 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
05/22/2003WO2002044168A3 Indole-type inhibitors of p38 kinase
05/22/2003WO2002030924A9 Quinazoline derivatives with anti-tumour activity
05/22/2003US20030096998 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections
05/22/2003US20030096990 Reacting phenylisocyanate compound with substituted hydrazono ester compound to form phenyl-2,4(1H,3H)-pyrimidinedione derivatives
05/22/2003US20030096858 The parent drug compound is modified by forming one or more of predetermined chemical arrangement within parent drug structure for programming specific course and rate of metabolism for drug that leads to inactive nontoxic metabolite
05/22/2003US20030096857 Novel antidiabetic agents
05/22/2003US20030096845 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
05/22/2003US20030096842 Inhibitors of farnesyl protein transferase
05/22/2003US20030096841 For treatment of cancers, heart disease, such as congestive heart failure, osteoporosis, genetic, inflammatory, allergic, and autoimmune diseases
05/22/2003US20030096836 2-Aroylimidazole compounds for treating cancer
05/22/2003US20030096833 Use in inhibiting inflammation, cell death and in treating shock and reperfusion injuries
05/22/2003US20030096828 Cyclic amide compound
05/22/2003US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition
05/22/2003US20030096820 Nitrogen containing heterobicycles as factor Xa inhibitors
05/22/2003US20030096819 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
05/22/2003US20030096812 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections
05/22/2003US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders
05/22/2003US20030096737 Caspase inhibitors and uses thereof
05/22/2003US20030096715 Lubricant composition, method for using and preparing thereof and molecular complex compound used for the same
05/22/2003US20030096138 An iridium complex of 2-(2-thienyl)-5-trifluoromethyl)pyridine compounds; light-emitting diodes
05/22/2003US20030095992 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots
05/22/2003US20030095958 Inhibiting beta amyloid converting enzyme responsible for A beta peptide cleavage to treat Alzheimer's Disease, Down's Syndrome, etc.
05/22/2003CA2468497A1 Heterocyclic derivatives of glycinamide and their medical use
05/22/2003CA2467391A1 Oligopeptides and compositions containing them as cathepsin s inhibitors
05/22/2003CA2467115A1 Process for production of pyrazole compounds
05/22/2003CA2467081A1 Pyrazole derivatives as psychopharmaceuticals
05/22/2003CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003CA2466955A1 Benzotriazepines as gastrin and cholecystokinin receptor ligands
05/22/2003CA2466665A1 Method to treat cystic fibrosis
05/22/2003CA2466465A1 Nk1 antagonists
05/22/2003CA2466440A1 Cannabinoid receptor ligands
05/22/2003CA2466055A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
05/22/2003CA2464861A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003CA2464419A1 Benzimidazoles useful as protein kinase inhibitors
05/22/2003CA2464347A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003CA2464069A1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
05/21/2003EP1312622A1 Process for the preparation of linear or branched 1,4-cis polybutadiene
05/21/2003EP1312609A1 Boronic ester and acid compounds, synthesis and uses
05/21/2003EP1312606A1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres
05/21/2003EP1312367A1 Heterocyclo-alkylsulfonyl pyrazolesa and their use as COX-2 inhibitors
05/21/2003EP1312364A1 Cytokine production inhibitors
05/21/2003EP1312347A1 Use of an extract of myrsine africana for the oxidative dyeing of keratinic fibres
05/21/2003EP1311622A1 Fibre-reactive monoazo dyestuffs
05/21/2003EP1311504A1 Tetrazolyl-phenyl acetamide glucokinase activators
05/21/2003EP1311502A1 Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatory disorders
05/21/2003EP1311501A1 Antithrombotic agents
05/21/2003EP1311500A2 Indole, azaindole and indazole derivatives having vegf inhibiting activity
05/21/2003EP1311499A2 Bicyclic compounds as h3 receptor ligands
05/21/2003EP1311488A1 Substituted imidazoles as tafia inhibitors
05/21/2003EP1311485A1 Processes for preparing cilostazol
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311480A1 New amidino derivatives and their use as thrombin inhibitors
05/21/2003EP1311473A2 Novel compounds inhibiting factor xa activity
1 ... 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 ... 1080